13F Pro Quality Score

53.2/100

Rank #1,293 of 2,879 stocksTOP 50%

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

75.8/100

Profitability

57.0/100

Balance Sheet

40.1/100

Earnings Quality

30.0/100

Free Cash Flow

66.6/100

Institutional Flow

60.1/100

Revenue Scale

36.3/100

Dilution Risk

13.0/100

PHR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Phreesia, Inc. (PHR), a Industrials sector company. 13F Pro's AI-powered ranking engine scores PHR at 53.2/100 on a 32-signal composite quality model, placing it at rank #1,293 of 2,879 stocks — the top half of the AI-ranked universe. PHR scores in the top quartile across revenue growth (75.8). Areas of concern include earnings quality (30.0) and revenue scale (36.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 13.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2027), Phreesia, Inc. reports quarterly revenue of $130.9M, net income of $3.0M, an operating margin of 5.1%. Top institutional holders of PHR by reported 13-F value include Pale Fire Capital SE, BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. PHR trades on the NYSE exchange and files with the SEC under CIK 1412408. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PHR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Phreesia, Inc. directly from SEC EDGAR. Phreesia, Inc.'s 13F Pro composite quality score has ranged between 8 and 67 since 2021, currently 53.2 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.

Revenue

Q1 2027

$130.9M

Net Income

Q1 2027

$3.0M

Free Cash Flow

Q1 2027

$19.6M

Operating Margin

Q1 2027

5.1%

ROIC

Q1 2027

1.9%

D/E Ratio

Q1 2027

0.25

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+34.9% YoY
$480.6MFY 2026
FY22 $213.2MFY23 $280.9MFY24 $356.3MFY26 $480.6M

Net Income

+101.7% YoY
$2.3MFY 2026
FY22 $-118.2MFY23 $-176.1MFY24 $-136.9MFY26 $2.3M

Operating Income

+95.2% YoY
$-6.6MFY 2026
FY22 $-116.8MFY23 $-176.6MFY24 $-136.5MFY26 $-6.6M

EPS (Diluted)

+101.6% YoY
$0.04FY 2026
FY22 $-2.37FY23 $-3.36FY24 $-2.51FY26 $0.04

Total Assets

+79.2% YoY
$663.8MFY 2026
FY22 $494.5MFY23 $370.1MFY24 $370.3MFY26 $663.8M

Total Debt

+773.7% YoY
$100.1MFY 2026
FY22 $13.2MFY23 $7.9MFY24 $11.5MFY26 $100.1M

Op. Cash Flow

+343.4% YoY
$78.8MFY 2026
FY22 $-74.7MFY23 $-90.1MFY24 $-32.4MFY26 $78.8M

AI Insight: PHR Financial Trends

Phreesia turned operating-income positive in Q2 2026 after four quarters of losses, but debt spiked 10x in Q1 2026 suggesting a major acquisition or financing event.

Revenue grew 28% from Q3 2024 ($102M) to Q2 2026 ($131M), with consistent quarter-over-quarter expansion.

Operating income swung from -$17M loss (Q3 2024) to +$7M profit (Q2 2026), marking path to sustained profitability.

Operating cash flow remained stable at $15M–$34M across last six quarters despite near-term P&L pressure.

Total debt jumped from $14M (Q3 2024) to $91M (Q2 2026), with spike to $100M in Q1 2026.

Debt-to-equity ratio deteriorated from 5.6% (Q3 2024) to 25.3% (Q2 2026). Monitor refinancing and debt paydown plans.

Operating margin turned positive only in Q2 2026; sustainability unclear given thin +5.3% margin.

AI Insight: PHR Ratio Trends

Phreesia swung from losses to profitability in Q2 2026, with operating margin at 5.1% after nine quarters below breakeven.

Operating margin improved from -1.3% in Q3 2025 to 5.1% in Q2 2026; NPM turned positive at 2.3%.

ROIC recovered to 6.0% in Q2 2026 from -5.1% in Q1 2026, signaling operational turnaround.

Leverage remained low: D/E 0.25 in Q2 2026, down from 0.30 in Q1 2026.

Q1 2026 profit reversals (OpMargin -4.4%, ROIC -5.1%) after strong Q4 2025 suggest volatility; monitor sustainability.

TTM OpMargin 0.7% remains thin; single unprofitable quarter could push rolling twelve months negative.

Get alerted when PHR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Phreesia, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of PHR

Put PHR on your watchlist

Track score changes the day Phreesia, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is PHR a good stock to buy?

13F Pro's AI-powered analysis of Phreesia, Inc. (PHR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PHR are available on the PHR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own PHR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PHR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Phreesia, Inc.'s investment landscape.